Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access
11141257 · 2021-10-12
Assignee
Inventors
Cpc classification
A61F2310/00029
HUMAN NECESSITIES
A61F2310/00023
HUMAN NECESSITIES
A61F2/0105
HUMAN NECESSITIES
A61F2310/00017
HUMAN NECESSITIES
A61F2210/0019
HUMAN NECESSITIES
A61F2220/0016
HUMAN NECESSITIES
International classification
Abstract
A blood filter delivery system for delivering a filter into a vein from either a femoral or jugular access. The preferred system includes an introducer and a push-rod with a spline member disposed along the push-rod and a pusher member disposed on a distal end. The spline member has a main body, first and second boss portions spaced apart along the longitudinal axis to provide a gap for retaining anchor members of the filter during delivery via the introducer. In an alternative embodiment, a preferred filter includes first and second filter structures diverging in opposite directions. A link is connected to portions of each of the first and second filter structures so that each filter structure can be independently collapsed into a generally cylindrical shape.
Claims
1. A blood filter and retrieval system comprising: a) a catheter sheath apparatus comprising a generally tubular member having a first end, intermediate section and a second end, the tubular member extending along a longitudinal axis, the first end having an inner surface exposed to the longitudinal axis, the inner surface surrounding a catheter lumen; b) a blood filter having a first diameter, the blood filter including a first filter structure comprising at least two elongated members, a second filter structure comprising at least two elongated members, one or more first links connected between elongated members of the first filter structure at a longitudinal middle section of the elongated members, portions of the one or more first links extending inwardly from the elongated members to a midpoint, and one or more second links connected between elongated members of the second filter structure at a longitudinal middle section of the elongated members, portions of the one or more second links extending inwardly from the elongated members to a midpoint, wherein each filter structure diverges from the longitudinal axis in opposite directions in a first expanded configuration of the filter structures having a first diameter; c) wherein each filter structure is collapsible into a reduced diameter shape in a second configuration having a second diameter that is smaller than the first diameter; d) a retrieval member contained in the catheter sheath in a first stored position and extendable from the catheter sheath to a second extended position that positions some or all of the retrieval member outside of the catheter sheath; and e) the retrieval member including a conically or frusto-conically shaped membrane and a grab device that is connectable to the filter structure at the link or links.
2. The system of claim 1, further comprising one or more hubs that each connect to one or more links.
3. The system of claim 1, wherein the grab device comprises a claw, the claw having a hook shape.
4. The system of claim 1, wherein the grab device comprises a pair of claws, each having a hook shape.
5. The system of claim 4, wherein each claw is configured to grab a different link.
6. The system of claim 5, wherein the retrieval member is housed in a tubular member.
7. The system of claim 1, wherein the grab device comprises a looped snare and the links comprise a hooked member.
8. The system of claim 1, wherein the conically or frusto-conically shaped membrane is reinforced with a plurality of ribs or struts.
9. The system of claim 1, further comprising an anchor on each elongated member.
10. A blood filter system, comprising: a) a tubular member having a first end, intermediate end and a second end, the tubular member extending along a longitudinal axis, the first end having an inner surface exposed to the longitudinal axis, the inner surface surrounding a tubular member bore; b) a first filter structure comprising at least two elongated members; c) a second filter structure comprising at least two elongated members; d) one or more first links connected between elongated members of the first filter structure at a longitudinal middle section of the elongated members, portions of the one or more first links extending inwardly from the elongated members; e) one or more second links connected between elongated members of the second filter structure, at a longitudinal middle section of the elongated members portions of the one ore more second links extending inwardly from the elongated members; f) wherein each filter structure diverges from the longitudinal axis in opposite directions in a first expanded configuration of the filter structures having a first diameter, and each filter structure is collapsible into second collapsed configuration having a second diameter that is smaller than the first diameter; g) a retrieval member movably mounted in the tubular member between retracted and extended positions; and h) wherein in the extended position, the retrieval member is connectable to a filter structure by engaging a link at a position outside of the tubular member bore.
11. The system of claim 10, wherein the retrieval member includes a grab device.
12. The system of claim 11, wherein the grab device includes one or more hook shaped members.
13. A method of retrieving a blood filter from the circulatory system of a patient comprising the steps of: a) providing a retrieval device and a retrieval sheath for retrieving a filter comprising a first filter structure comprising at least two elongated members, a second filter structure comprising at least two elongated members, one or more first links connected between elongated members of the first filter structure at a longitudinal middle section of the elongated members, portions of the one or more first links extending inwardly from the elongated members, and one or more second links connected between elongated members of the second filter structure at a longitudinal middle section of the elongated members, portions of the one or more second links extending inwardly from the elongated members; b) wherein in step “a” each filter structure diverges from the longitudinal middle section in opposite directions in a first expanded configuration of the filter structures having a first diameter, and each filter structure is collapsible into a reduced diameter shape in a second configuration having a second diameter that is smaller than the first diameter; c) wherein the filter structures are engaged against a vessel wall of an implantation site; and d) retrieving the filter by forming an access to the implantation site via a selected vessel and retrieving the filter with the retrieval device into the retrieval sheath by connecting the retrieval device with one or more of the links.
14. The method of claim 13, wherein the retrieval device includes a grab device that is connectable to one or more of the links.
15. The method of claim 13, further comprising a hub that connects with one or more of the links and in step “d” the retrieval device connects with the hub.
16. The method of claim 13, wherein each elongated member has an anchor and the retrieval device includes a cone or frusto-cone shaped portion that engages and collapses the elongated members to remove the anchors from the vessel wall.
17. The method of claim 16, wherein the anchor has a hook shape.
18. The method of claim 14, wherein the grab device includes one or more hook shaped members.
19. The method of claim 14, wherein the grab device comprises a pair of claws, each having a hook shape.
20. The method of claim 14, wherein the grab device includes first and second interlocking portions, the first interlocking portion on the filter, the second interlocking portion on the grab device.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate presently preferred embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain features of the invention.
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
(16) The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
(17) As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. Also, as used herein, the terms “patient”, “host” and “subject” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment.
(18)
(19) Referring back to
(20) As implanted, the blood filter 14 may include first and second filter structures 14a and 14b that diverge away from a longitudinal axis A-A in opposite directions in the implanted configuration, as shown here in
(21) In the preferred embodiments, the first and second filter structures can be integrated with each other. For example, with reference to
(22) In the preferred embodiments, the wire can be a material selected from a group consisting essentially of shape memory material, super-elastic material, linear-elastic material, metal, alloys, polymers and combinations thereof. Preferably, the wire has a cross-sectional area of about 0.00013 squared inches.
(23) Instead of joining the wires together proximate the middle sections of the wires, a hub 50 can be utilized to constrain the plurality of wires forming the first and second filter structures, as shown here in
(24) Instead of making the filter out of wires, a blood filter of generally the same configuration can be cut out from a thin tubular member using a suitable cutting technique such as, for example, laser cutting (as described and shown in U.S. Pat. No. 6,099,549, which is incorporated by reference herein in its entirety), electric-discharge machining or via etching.
(25) Each of the filter structures 14a and 14b preferably respectively has a link 30a and link 30b, as shown in
(26) Referring again to
(27) Each link can be coupled to the anchor member anywhere along the length of the anchor member including any portions proximate the hook 40. Preferably, the link is anchored at a suitable distance from the hook 40 so that tissue in-growth does not substantially prevent the link from swiveling or pivoting. In a preferred embodiment, the link can be made out of a material other than the material or materials in which the filter anchor member is made of. For example, the link can be made out of suture material (resorbable and non-resorbable type) or carbon nanotubes or metal wire.
(28) Variations of the filter 14 can be utilized by a clinician for delivery and extraction. For example, as shown in
(29) Several alternative configurations are exemplarily illustrated in
(30) In the preferred embodiments, retention member 14h is a curved hook 40 that extends for at least forty-five degrees (45°) about a center, and in one variation, the hook can subtend for more than three hundred and sixty degrees (360°) about a center. In the preferred embodiments, the hook 40 can be made from material selected from a group consisting essentially of shape memory material, super-elastic material, linear-elastic material, metal, alloys, polymers and combinations thereof.
(31) Most preferably, the hook 40 is of the configuration shown in
(32) Of particular interest is the ability of the preferred hook to take on a curved configuration in an operative condition and towards a generally linear configuration in another condition when axial force is applied along the length of the wire. Details of this ability of the hook (and the pusher assembly along with a similar catheter assembly) are shown and described in U.S. Pat. No. 6,258,026 issued Ravenscroft et al on Jul. 10, 2001; U.S. Pat. No. 6,007,558 issued to Ravenscroft et al on Dec. 28, 1999, provisional application Ser. No. 60/680,601 filed on May 12, 2005, and as well as in a PCT Patent Application that claims priority to the antecedent provisional patent application, which PCT Patent Application is entitled “Removable Embolus Blood Clot Filter,” having PCT Application No. PCT/US06/17889 filed on May 9, 2006, which documents are incorporate herein by reference in their entirety.
(33) The filter 14 can be delivered or implanted using a delivery system 100, illustrated in
(34) Referring to
(35) The intermediate end 15b (
(36) The splined boss 20 can be connected to the pusher 12 so that axial movement of the pusher distally would cause the filter 14 to be pushed out of catheter sheath 15 for delivery into the blood vessel. The splined boss 20 may be provided with an opening 20d so that nub 32a or 32b can be inserted into the opening while the filter 14 is in a pre-delivery configuration in sheath 15. Alternatively, the catheter sheath 15 may include a housing or body coupled at the second 15c end of the sheath 15 while an elongated member 12 can be used to push a boss portion 20b, which is part of the filter (
(37) Each of the various embodiments of the splined boss 20 is utilized to maintain the hooks 40 in a non-interference configuration, i.e., non-crossed configuration, while the filter 14 is in the sheath 15. In these embodiments, the splined boss is utilized to transmit motion in the distal direction from the handle 12a into the anchor members 14a1, 14a2, and 14a3 and so on during delivery of the filter out of the sheath 15 into the blood vessel. The splined boss achieves this by having various cross-sectional areas of the groove 20c where at least one cross-sectional area of the groove is smaller than the smallest cross-sectional area (e.g. 14ab) of the anchor member 14a1 (but exclusive of the cross-sectional area of the hooks 40, which is smaller than any of the above). Further, where the splined boss is integral with the pusher 12, the boss is designed so that movement of the splined boss 20 in the proximal direction while in the sheath 15 is restrained so that substantial inadvertent movement of the pusher 12 in the proximal direction does not result in the filter 14 being pulled towards the Y-adapter 10.
(38) In the configurations of
(39) The hooks of the preferred embodiments allow for removal of the filter 14 with minimal injury to a blood vessel. In particular, with reference to
(40) Once implanted, the hooks 40 may be removed from the Inferior Vena Cava (“IVC”) wall during filter removal procedure when longitudinal force is applied to the hub 50 in the direction of the BF. Under this concentrated stress, the hooks will tend to straighten and transition to the martensitic state, thereby becoming super-elastic. Thus the hooks 40 are designed to bend toward a substantially straight configuration as seen, for example in
(41) Alternatively, a reduction in temperature below an Af temperature can be applied to the shape memory material to cause a change in the crystalline phase of the material so as to render the material malleable during loading or retrieval of the filter. Various techniques can be used to cause a change in crystalline phase such as, for example, cold saline, low temperature fluid or thermal conductor.
(42) In another embodiment, shown in
(43)
(44) In the preferred embodiments, a kit is provided that includes the filter delivery system 100 along with instructions IFU for a clinician to deliver the filter to a target site in a host. The instructions on delivery of the filter can include the following guidelines.
(45) i. A suitable femoral or jugular venous vessel site in the host may be selected. Typically, this is the vessel on either the left or right side, depending upon the patient's size or anatomy, the clinician's preference and/or the location of a venous thrombosis.
(46) ii. The site can be nicked with a blade and the vein punctured with a suitable entry needle, such as an 18-gage needle, or trocar.
(47) iii. A suitable guidewire, such as a J-tipped guidewire, is inserted into the needle and advanced into a distal vena cava or iliac vessel where a filter is to be delivered. Once the guidewire is in position, the entry needle is removed from the patient and slipped off the proximal end of the guide wire.
(48) iv. The dilator 18 is inserted into the introducer 16. Then the proximal end of the guidewire is inserted into both the introducer 16 and dilator 18. Saline or a suitable bio-compatible fluid is provided to the introducer valve 16d to remove air in the introducer 16, and then the assembly is inserted into the patient and advanced along the guidewire until it reaches a desired position in the vena cava or iliac vessel. Positioning of the introducer tip 16a1 within the vein at the site for delivering the filter may be confirmed by fluoroscopy, aided by the radio-opaque markers on or within the introducer 16. Contrasting agent or dye can also be provided to the ports 18d (or 194 of
(49) v. The dilator 18 can be separated from a snap-fit of the introducer 16 by bending and pulling the two components. The introducer can be left with its tip in the vena cava. Fluid can be introduced into the introducer via valve 16d.
(50) vi. The filter 14, which is pre-stored in the catheter sheath 15, can be coupled to the coupling port 16b via the snap-fitting, and saline can be permitted to flow through the catheter sheath 15 to provide lubricity between various components of the delivery system 100. The saline may be chilled during portions of the procedure. Similarly, the saline may be warmed during portions of the procedure, such as just prior to releasing the filter into the vein, to help raise the filter and pusher assembly 12 components above the martensitic-to-austenitic transition temperature, causing the filter to seek its annealed shape. The introducer 16, catheter sheath 15 and elongated pusher assembly 12 are preferably held in a linear configuration to avoid kinking and minimize friction. The filter 14 is physically advanced from the catheter sheath 15 through the introducer 16 to a position near the distal tip 16a1 of the introducer 16. The advancement of the filter 14 can be accomplished by maintaining the introducer 16 stationary while pushing on the handle 12a of the elongated pusher assembly 12 in the distal direction. The filter 14 is maintained inside the introducer 16, i.e., undeployed at this point. Markings on the pusher assembly 12 may permit the clinician to determine the position of the filter 14 with respect to the end of the introducer 16. Additionally, fluoroscopy may be used to track the position of the filter 14 within the introducer 16 and with respect to the patient. When the filter hub 50 approaches the distal end of the introducer 16, the filter is ready to be deployed.
(51) vii. To deploy the filter 14, the elongated pusher assembly 12 and the introducer hub 16c are moved relative to each other over a first predetermined distance. At this point, the introducer 16 is retracted proximally while the pusher 12 is held in stationary position to allow the anchor members 14b1-14b5 to become unconstrained by the introducer sheath 16a and free to expand radially. Hooks 40 at the ends of the anchor members 14b1-14b5 begin to dig or penetrate into the blood vessel wall to maintain the filter 14 at approximately the desired location.
(52) It should be noted that the instructions IFU for the kit could be embodied in any suitable format such as, for example, in paper or electronic forms (e.g., a web site, PDFs, video or audio).
(53) To recover the filter 14, there are at least three different embodiments of a recovery device suitable to remove filter 14. The first embodiment is shown in
(54) Referring to
(55) As shown in
(56) Retrieval can be performed as follows. In
(57) In the second embodiment illustrated in
(58) In the third embodiment illustrated in
(59) The blood filter and retrieval system may comprise: a catheter sheath apparatus comprising a generally tubular member having a first end 15a, intermediate section 15b and a second end 15c, the tubular member extending along a longitudinal axis A-A, the first end having an inner surface 15ID exposed to the longitudinal axis, the inner surface surrounding a catheter lumen or bore; a blood filter having a first diameter, the blood filter including a first filter structure 14a comprising at least two elongated members, a second filter structure 14b comprising at least two elongated members, one or more first links 30a1, 30a2 connected between elongated members of the first filter structure at a longitudinal middle section of the elongated members, portions of the one or more first links extending inwardly from the elongated members to a midpoint, and one or more second links connected between elongated members of the second filter structure 14b at a longitudinal middle section of the elongated members, portions of the one or more second links extending inwardly from the elongated members to a midpoint, wherein each filter structure diverges from the longitudinal axis A-A in opposite directions in a first expanded configuration of the filter structures having a first diameter; wherein each filter structure is collapsible into a reduced diameter shape in a second configuration having a second diameter that is smaller than the first diameter; a retrieval member 240, 240′, 240″ contained in the catheter sheath 15 in a first stored position and extendable from the catheter sheath to a second extended position that positions some or all of the retrieval member 240, 240′, 240″ outside of the catheter sheath; and the retrieval member including a conically or frusto-conically shaped membrane and a grab device that is connectable to the filter structure at a link or links.
(60) As illustrated in
(61) As illustrated in
(62) As illustrated in
(63) As illustrated in
(64) As illustrated in
(65) As illustrated in
(66) As illustrated in
(67) As illustrated in
(68) Also, the blood filter system may comprise a tubular member having a first end 15a, intermediate section 15b and a second end 15c, the tubular member extending along a longitudinal axis A-A, the first end having an inner surface 15ID exposed to the longitudinal axis, the inner surface surrounding a tubular member bore; a first filter structure 14a comprising at least two elongated members; a second filter structure 14b comprising at least two elongated members; one or more first links connected between elongated members of the first filter structure at a longitudinal middle section of the elongated members, portions of the one or more first links extending inwardly from the elongated members; one or more second links connected between elongated members of the second filter structure, at a longitudinal middle section of the elongated members portions of the one or more second links extending inwardly from the elongated members; wherein each filter structure diverges from the longitudinal axis in opposite directions in a first expanded configuration of the filter structures having a first diameter, and each filter structure is collapsible into second collapsed configuration having a second diameter that is smaller than the first diameter; a retrieval member movably mounted in the tubular member between retracted and extended positions; and wherein in the extended position, the retrieval member 240, 240′, 240″ is connectable to a filter structure by engaging a link or links at a position outside of the tubular member bore.
(69) As illustrated in
(70) As illustrated in
(71) Utilizing the embodiments set forth in
(72) The method may further comprise retrieval of the blood filter by forming an access to the implantation site via a selected vessel and retrieving the filter with a retrieval device into a retrieval sheath, as illustrated in
(73) The method may further comprise a retrieval device which includes a grab device that is connectable to one or more of the links, as illustrated in
(74) The method may further comprise a hub that connects with one or more of the links and wherein the retrieval device connects with the hub, as illustrated in
(75) In the method each elongated member may have an anchor and the retrieval device may include a cone or frusto-cone shaped portion that engages and collapses the elongated members to remove the anchors from the vessel wall, as illustrated in
(76) In the method, the anchor may have a hook shape, as illustrated in
(77) In the method, the grab device may include one or more hook shaped members, as illustrated in
(78) In the method, the grab device may include a pair of claws, each claw having a hook shape, as illustrated in
(79) In the method, the grab device may include first and second interlocking portions, the first interlocking portion on the filter, the second interlocking portion on the grab device, as illustrated in
(80) By virtue of the filter, delivery system and retrieval system described herein, a method of delivering a filter and extracting such filter can be provided. In particular, the method allows for delivery of a blood filter from either an incision in the femoral or jugular vessels. The method can be achieved by providing a filter having first and second filter structures that diverge away from a longitudinal axis in opposite directions in a first configuration and a link connected to discrete portions of each of the first and second filter structures so that each filter structure is independently collapsed into a generally cylindrical shape in a second configuration; storing the filter proximate a distal end of a generally tubular sheath having a first end, intermediate end and a second end defining a longitudinal axis extending therethrough, the first end having an inner surface exposed to the longitudinal axis, the inner surface having a plurality of notches formed on the inner surface, the intermediate end including a boss portion coupled to the pusher and disposed in the tubular member having a plurality of grooves formed in the boss portion; accessing an implantation site via one of the femoral or jugular vessels; and releasing the filter from the sheath proximate the implantation site to engage the filter structures against a vessel wall of the implantation site. Retrieval of the filter can be performed by forming an access to the implantation site via one of the femoral or jugular vessels; and retrieving the filter into a retrieval sheath. The retrieving can include retracting a portion of at least one hook from one of the filter structures to disengage the hook from the vessel wall.
(81) In another embodiment, bio-active agents can be incorporated with the blood filter or filter delivery system, such as by way of a coating on parts of the filter delivery components (e.g., the pusher member 12c or the tip of the introducer sheath 16a), or dissolvable structures on, within or attached to the filter delivery components. Alternatively, bio-active agents can be delivered to the region of the filter at the time of the filter emplacement by means of the introducer, either before or after delivery of the filter. Bio-active agent can be included as part of the filter delivery system in order to treat or prevent other conditions (such as infection or inflammation) associated with the filter, or to treat other conditions unrelated to the filter itself. More specifically, bio-active agents may include, but are not limited to:
(82) pharmaceutical agents, such as, for example, anti-proliferative/antimitotic agents including natural products such as vinca alkaloids (i.e. vinblastine, vincristine, and vinorelbine), paclitaxel, epidipodophyllotoxins (i.e. etoposide, teniposide), antibiotics (dactinomycin (actinomycin D) daunorubicin, doxorubicin and idarubicin), anthracyclines, mitoxantrone, bleomycins, plicamycin (mithramycin) and mitomycin, enzymes (L-asparaginase which systemically metabolizes L-asparagine and deprives cells which do not have the capacity to synthesize their own asparagine);
(83) antiplatelet agents such as G(GP) IIb/IIIa inhibitors and vitronectin receptor antagonists;
(84) anti-proliferative/antimitotic alkylating agents such as nitrogen mustards (mechlorethamine, cyclophosphamide and analogs, melphalan, chlorambucil), ethylenimines and methylmelamines (hexamethylmelamine and thiotepa), alkyl sulfonates-busulfan, nirtosoureas (carmustine (BCNU) and analogs, streptozocin), and trazenes-dacarbazinine (DTIC);
(85) anti-proliferative/antimitotic antimetabolites such as folic acid analogs (methotrexate), pyrimidine analogs (fluorouracil, floxuridine, and cytarabine), purine analogs and related inhibitors (mercaptopurine, thioguanine, pentostatin and 2-chlorodeoxyadenosine {cladribine});
(86) platinum coordination complexes (cisplatin, carboplatin), procarbazine, hydroxyurea, mitotane, aminoglutethimide;
(87) hormones (i.e. estrogen);
(88) anti-coagulants (heparin, synthetic heparin salts and other inhibitors of thrombin);
(89) fibrinolytic agents (such as tissue plasminogen activator, streptokinase and urokinase), aspirin, dipyridamole, ticlopidine, clopidogrel, abciximab;
(90) antimigratory agents;
(91) antisecretory agents (e.g., breveldin);
(92) anti-inflammatory agents, such as adrenocortical steroids (cortisol, cortisone, fludrocortisone, prednisone, prednisolone, 6α-methylprednisolone, triamcinolone, betamethasone, and dexamethasone), non-steroidal agents (salicylic acid derivatives i.e. aspirin;
(93) para-aminophenol derivatives i.e. acetominophen;
(94) indole and indene acetic acids (indomethacin, sulindac, and etodalac), heteroaryl acetic acids (tolmetin, diclofenac, and ketorolac), arylpropionic acids (ibuprofen and derivatives), anthranilic acids (mefenamic acid, and meclofenamic acid), enolic acids (piroxicam, tenoxicam, phenylbutazone, and oxyphenthatrazone), nabumetone, gold compounds (auranofin, aurothioglucose, gold sodium thiomalate);
(95) immunosuppressives: (cyclosporine, tacrolimus (FK-506), sirolimus (rapamycin), azathioprine, mycophenolate mofetil);
(96) angiogenic agents, such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF);
(97) angiotensin receptor blockers;
(98) nitric oxide donors;
(99) anti-sense oligionucleotides and combinations thereof;
(100) cell cycle inhibitors, such as mTOR inhibitors, and growth factor receptor signal transduction kinase inhibitors;
(101) retenoids;
(102) cyclin/CDK inhibitors;
(103) HMG co-enzyme reductase inhibitors (statins); and
(104) protease inhibitors.
(105) Suitable polymer coating materials include polycarboxylic acids, cellulosic polymers, including cellulose acetate and cellulose nitrate, gelatin, polyvinylpyrrolidone, cross-linked polyvinylpyrrolidone, polyanhydrides including maleic anhydride polymers, polyamides, polyvinyl alcohols, copolymers of vinyl monomers such as EVA, polyvinyl ethers, polyvinyl aromatics, polyethylene oxides, glycosaminoglycans, polysaccharides, polyesters including polyethylene terephthalate, polyacrylamides, polyethers, polyether sulfone, polycarbonate, polyalkylenes including polypropylene, polyethylene and high molecular weight polyethylene, halogenated polyalkylenes including polytetrafluoroethylene, polyurethanes, polyorthoesters, proteins, polypeptides, silicones, siloxane polymers, polylactic acid, polyglycolic acid, polycaprolactone, polyhydroxybutyrate valerate and blends and copolymers thereof, coatings from polymer dispersions such as polyurethane dispersions (for example, BAYHDROL® fibrin, collagen and derivatives thereof, polysaccharides such as celluloses, starches, dextrans, alginates and derivatives, hyaluronic acid, squalene emulsions. Polyacrylic acid, available as HYDROPLUS® (Boston Scientific Corporation, Natick, Mass.), and described in U.S. Pat. No. 5,091,205, the disclosure of which is hereby incorporated herein by reference in its entirety, is particularly desirable. Another material can also be a copolymer of polylactic acid and polycaprolactone.
(106) While the present invention has been disclosed with reference to certain preferred embodiments, numerous modifications, alterations, and changes to the described embodiments are possible without departing from the sphere and scope of the present invention, which is described, by way of example, in the appended numbered paragraphs below. Accordingly, it is intended that the present invention not be limited to the described embodiments, but that it have the full scope defined by the language of at least the following paragraphs, and equivalents thereof